AbbVie Collaborates with Global Health Authorities to Investigate its Kaletra/Aluvia (lopinavir/ritonavir) Against COVID-19

Shots:

• AbbVie collaborates with global health authorities, including the FDA, CDC, BARDA, NIH, EU health authorities and Chinese officials to determine the safety & efficacy of Kaletra/Aluvia against COVID-19
• AbbVie donated Aluvia to the Chinese government for experimental use against COVID-19 and has joined the Innovative Medicines Initiative to support research and discovery of therapies against COVID-19
• AbbVie is actively evaluating the increased demand for Kaletra/Aluvia and has taken steps to improve supply for COVID-19 patients without impacting treatment supply for HIV patients

Click here ­to­ read full press release/ article | Ref: AbbVie | Image: Telegram